Literature DB >> 21464405

Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase.

Carlos E Vigil1, Sa A Wang, Jorge E Cortes, Carlos Bueso-Ramos, Srdan Verstovsek, Roman Shinder, Su S Chen, Ruth L Katz, Abha Khanna, Bita Esmaeli, John T Manning, M James You, Roberto N Miranda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21464405      PMCID： PMC4874210          DOI： 10.1200/JCO.2010.34.1610

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  18 in total

1.  Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.

Authors:  S Sacchi; H M Kantarjian; S O'Brien; J Cortes; M B Rios; F J Giles; M Beran; C A Koller; M J Keating; M Talpaz
Journal:  Cancer       Date:  1999-12-15       Impact factor: 6.860

2.  Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis.

Authors:  Hermine Agis; Karl Sotlar; Peter Valent; Hans-Peter Horny
Journal:  Leuk Res       Date:  2005-10       Impact factor: 3.156

3.  Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation.

Authors:  Wolfgang R Sperr; Johannes Drach; Alexander W Hauswirth; Jutta Ackermann; Margit Mitterbauer; Gerlinde Mitterbauer; Manuela Foedinger; Christa Fonatsch; Ingrid Simonitsch-Klupp; Peter Kalhs; Peter Valent
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

4.  Blast crisis of chronic granulocytic leukemia with mast cell and basophilic precursors.

Authors:  J Soler; M O'Brien; J T de Castro; J F Miguel; L Kearney; J M Goldman; D Catovsky
Journal:  Am J Clin Pathol       Date:  1985-02       Impact factor: 2.493

Review 5.  Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells.

Authors:  Peter Valent; Puchit Samorapoompichit; Wolfgang R Sperr; Hans-Peter Horny; Klaus Lechner
Journal:  Hematol J       Date:  2002

6.  Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase.

Authors:  Hagop M Kantarjian; Jorge Cortes; Susan O'Brien; Francis J Giles; Maher Albitar; Mary Beth Rios; Jianqin Shan; Stefan Faderl; Guillermo Garcia-Manero; Deborah A Thomas; Debra Resta; Moshe Talpaz
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

7.  JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome.

Authors:  Pei Lin; Rajyalakshmi Luthra; Roberto H Nussenzveig; L Jeffrey Medeiros
Journal:  Hum Pathol       Date:  2010-02-12       Impact factor: 3.466

8.  Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation.

Authors:  N C Cross; L Feng; A Chase; J Bungey; T P Hughes; J M Goldman
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

9.  Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia.

Authors:  F Morel; A Herry; M-J Le Bris; P Morice; P Bouquard; J-F Abgrall; C Berthou; M De Braekeleer
Journal:  Cancer Genet Cytogenet       Date:  2003-12

10.  Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis.

Authors:  Roberto Cairoli; Giovanni Grillo; Alessandro Beghini; Giorgia Cornacchini; Lidia Larizza; Enrica Morra
Journal:  Hematol J       Date:  2004
View more
  3 in total

1.  Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components.

Authors:  Sa A Wang; Lloyd Hutchinson; Guilin Tang; Su S Chen; Patricia M Miron; Yang O Huh; Dan M Jones; Carlos Bueso-Ramos; Srdan Verstovsek; L Jeffrey Medeiros; Roberto N Miranda
Journal:  Am J Hematol       Date:  2013-03       Impact factor: 10.047

2.  A case report and case review: Chronic myeloid leukemia (CML) blast phase with myelomastocytic differentiation.

Authors:  Jinming Song; Kenian Liu; Javier Pinilla-Ibarz; Hailing Zhang
Journal:  Leuk Res Rep       Date:  2020-09-28

Review 3.  A Rare Case of Systemic Mastocytosis with Associated Hematologic Neoplasm (SM-AHN) Involving Chronic Myeloid Leukemia: A Case Report and Literature Review.

Authors:  Feryal A Ibrahim; Mohammad A J Abdulla; Dina Soliman; Ahmad Al Sabbagh; Zafar Nawaz; Susanna Jane Akiki; Hawraa Shwaylia; Mohamed A Yassin
Journal:  Am J Case Rep       Date:  2020-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.